MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,861,000 | +56.2% | 1,519,888 | +24.8% | 0.00% | – |
| Q1 2020 | $2,472,000 | +25.0% | 1,217,647 | +33.0% | 0.00% | – |
| Q4 2019 | $1,978,000 | +37.9% | 915,859 | -1.7% | 0.00% | – |
| Q3 2019 | $1,434,000 | -61.1% | 931,433 | +4.9% | 0.00% | – |
| Q2 2019 | $3,685,000 | +23.7% | 888,008 | +24.7% | 0.00% | – |
| Q1 2019 | $2,978,000 | +75.3% | 712,325 | +20.3% | 0.00% | – |
| Q4 2018 | $1,699,000 | -70.8% | 592,067 | +1.8% | 0.00% | – |
| Q3 2018 | $5,817,000 | +49.4% | 581,696 | +5.6% | 0.00% | – |
| Q2 2018 | $3,893,000 | +2333.1% | 550,774 | +1210.8% | 0.00% | – |
| Q1 2018 | $160,000 | -42.7% | 42,019 | +22.6% | 0.00% | – |
| Q4 2017 | $279,000 | +18.7% | 34,277 | -14.5% | 0.00% | – |
| Q3 2017 | $235,000 | – | 40,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |